Evidence that protective Fc-receptor-blocking antibodies in renal transplantation are alloantibodies not autoantibodies.
We have previously shown that the presence in pretransplant recipient sera of Fc receptor blocking antibodies detected by the EA inhibition assay is correlated with improved allograft survival. Twenty-four such sera were assessed for the presence of autoantibodies by the EA inhibition and lymphocytotoxicity assays. No autolymphocytotoxic antibodies were found, and autologous EA inhibition was noted in only one case. EA-inhibiting alloantibodies did occur, and their presence was correlated with improved allograft survival. Sera from 37 dialysis patients were also studied, and neither autologous EA inhibiting nor autologous lymphocytotoxic antibodies were present. Thus Fc receptor blocking alloantibodies that were correlated with improved renal transplant survival were not autoantibodies.
D001323:Autoantibodies / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D006085:Graft Survival; D006801:Humans; D007518:Isoantibodies / Q000276:immunology*; D007668:Kidney / Q000276:immunology; D016030:Kidney Transplantation; D011961:Receptors, Fc / Q000276:immunology*; D012397:Rosette Formation
D001323:Autoantibodies; D007518:Isoantibodies; D011961:Receptors, Fc